The Flex Co. Acquires Allbodies Inc.

CALIDA GROUP Acquires Cosabella

May 19, 2022

Consumer Products

The CALIDA GROUP has acquired American premium lingerie and loungewear brand Cosabella, purchasing 100% of the company for a total package of USD 80 million including earn-out. The deal strengthens CALIDA's core underwear portfolio, provides a US hub for launching its CALIDA and AUBADE brands, and leverages Cosabella's strong DTC/e-commerce business (online share >50%) and ~50 employees to drive growth in the US and Europe.

Trafilea Acquires The BodCon

December 2, 2022

Media & Entertainment

Trafilea, the e‑commerce group behind Shapermint and Truekind, has acquired The BodCon — a virtual annual conference focused on body confidence — and its BodPod podcast. The founders Jess Hunichen and Emily Ward will remain with the business to continue operating The BodCon as a standalone brand; financial terms were not disclosed.

Linden Capital Partners Acquires LifeStyles Healthcare

December 1, 2022

Consumer Products

Linden Capital Partners has acquired LifeStyles Healthcare, a global sexual health and wellness platform, from a consortium of investors including Trustar Capital and Humanwell Healthcare. The deal excludes LifeStyles' Chinese operations (including the Jissbon brand), which will be retained by the selling shareholders; Linden has named Laurent Faracci as incoming CEO and Ron Fugate as Chairman to drive commercial, brand, and innovation-led growth.

Cengage Group Acquires Visible Body

January 13, 2025

Education

Cengage Group has acquired Visible Body, a provider of interactive 3D anatomy and science visualization software, to enhance its science offerings across higher education and K–12. The deal will integrate Visible Body’s 3D models and AR/mixed-reality experiences into Cengage’s course materials and platforms to deepen learner engagement and expand product capabilities. Vicksburg Capital Partners served as exclusive financial advisor to Visible Body on the transaction.

Biogen Acquires Alcyone Therapeutics

September 19, 2025

Medical Devices

Biogen has acquired Alcyone Therapeutics to obtain the ThecaFlex DRx intrathecal drug‑delivery system, integrating Alcyone employees into Biogen’s product delivery solutions team. Alcyone will receive $85 million upfront plus contingent milestone payments; Biogen will handle development, commercialization and manufacturing of ThecaFlex DRx while Alcyone’s remaining therapeutic assets are being divested into Neela Therapeutics.

Aditxt, Inc. Acquires Evofem Biosciences, Inc.

December 12, 2023

Biotechnology

Aditxt, Inc. has entered into a definitive agreement to acquire Evofem Biosciences in a stock-and-debt assumption transaction that will make Evofem a wholly owned subsidiary of Aditxt pending closing (anticipated H1 2024). The deal transfers approximately $100 million of consideration via stock issuance and assumption of certain senior indebtedness, and positions Aditxt to establish a women's health mission and scale Evofem’s hormone-free contraceptive Phexxi and other women's health products globally.